MedTrace Logo

Lipase Levels and Coronavirus Disease 2019

NCT05601258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2022-11-01

No results posted yet for this study

Summary

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.

In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.

Conditions

Interventions

OTHER

Age, gender, hospitalization and mortality rates will be compared

Age, gender, hospitalization and mortality rates will be compared

Sponsors & Collaborators

  • Uşak University

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2021-07-09
Completion
2021-07-09

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05601258 on ClinicalTrials.gov